• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[苯乙二醛修饰的尿激酶型纤溶酶原激活剂的特性研究]

[Characterization of urokinase type plasminogen activator modified by phenylglyoxal].

作者信息

Mukhametova L I, Aĭsina R B, Lomakina G Iu, Varfolomeev S D

机构信息

Chemical Faculty, Moscow State University, Vorob'evy gory, Moscow, 119899 Russia.

出版信息

Bioorg Khim. 2002 Jul-Aug;28(4):308-14.

PMID:12197387
Abstract

A chemical modification of single-chain urokinase-type plasminogen activator (scu-PA) with phenylglyoxal under mild conditions resulted in the scu-PA derivatives with various numbers of the modified Arg residues. The study of properties of the resulting derivatives demonstrated that the modification of 4-12 Arg residues did not cause any loss of the activator, fibrinolytic, and potential amidase activities of the activator. The scu-PA with four modified Arg residues was found to be the most stable derivative in human blood plasma; it causes a more efficient lysis of plasma clots than the native activator. Three of four modified Arg residues are supposed to be within the 178RRHRGGS184 cluster, which was localized in the superficial loop of the scu-PA globule and was shown to interact with the complementary series of negatively charged residues in the molecule of the main plasma inhibitor PAI-1. The neutralization of positively charged Arg residues in this cluster decreases the affinity of scu-PA and the double chain urokinase-type plasminogen activator for PAI-1, which results in an enhancement of the stability in plasma and the fibrinolytic efficiency of the activator. The English version of the paper: Russian Journal of Bioorganic Chemistry, 2002, vol. 28, no. 4; see also http://www.maik.ru.

摘要

在温和条件下用苯乙二醛对单链尿激酶型纤溶酶原激活剂(scu-PA)进行化学修饰,得到了具有不同数量修饰精氨酸(Arg)残基的scu-PA衍生物。对所得衍生物性质的研究表明,修饰4 - 12个Arg残基不会导致激活剂的激活、纤维蛋白溶解及潜在酰胺酶活性丧失。发现具有四个修饰Arg残基的scu-PA是在人血浆中最稳定的衍生物;它比天然激活剂能更有效地溶解血浆凝块。四个修饰的Arg残基中有三个推测位于178RRHRGGS184簇内,该簇位于scu-PA球状体的表面环中,并已证明其与主要血浆抑制剂PAI-1分子中带负电荷的互补序列相互作用。该簇中带正电荷的Arg残基被中和会降低scu-PA和双链尿激酶型纤溶酶原激活剂对PAI-1的亲和力,这导致激活剂在血浆中的稳定性增强以及纤维蛋白溶解效率提高。论文英文版本:《俄罗斯生物有机化学杂志》,2002年,第28卷,第4期;另见http://www.maik.ru 。

相似文献

1
[Characterization of urokinase type plasminogen activator modified by phenylglyoxal].[苯乙二醛修饰的尿激酶型纤溶酶原激活剂的特性研究]
Bioorg Khim. 2002 Jul-Aug;28(4):308-14.
2
Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.通过在纤溶酶切割位点融合获得的嵌合型(组织型/尿激酶型)纤溶酶原激活剂的特性。
Thromb Haemost. 1993 May 3;69(5):466-72.
3
Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.组织型纤溶酶原激活剂(t-PA)与单链尿激酶型纤溶酶原激活剂(scu-PA)在体外对血凝块溶解的协同作用及其作用机制。
Thromb Haemost. 1987 Jun 3;57(3):372-3.
4
Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.低分子量和高分子量单链尿激酶型纤溶酶原激活剂的体外纤溶活性比较
Thromb Haemost. 1993 Sep 1;70(3):481-5.
5
Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.苯乙二醛修饰的α2-抗纤溶酶对尿激酶诱导的纤维蛋白溶解的影响。
Thromb Haemost. 1998 Oct;80(4):637-44.
6
Pharmacokinetics of single chain forms of urokinase-type plasminogen activator.单链尿激酶型纤溶酶原激活剂的药代动力学
J Pharmacol Exp Ther. 1987 Jul;242(1):245-50.
7
A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.一种用于检测人体体液中凝血酶裂解的双链尿激酶型纤溶酶原激活剂的灵敏生物免疫测定法。
Thromb Haemost. 1996 Jun;75(6):908-14.
8
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.凝血酶激活的纤溶抑制物(TAFI)以纤溶酶原激活物浓度依赖的方式影响纤维蛋白溶解。在内源性凝块溶解模型中对七种纤溶酶原激活物的研究。
Thromb Haemost. 2004 Mar;91(3):473-9. doi: 10.1160/TH03-06-0377.
9
Importance of plasminogen activator inhibitor type 1 (PAI-1) for preventing single chain urokinase plasminogen activator (scu-PA) conversion into two chain urokinase plasminogen activator (tcu-PA) in plasma in vitro.纤溶酶原激活物抑制剂1(PAI-1)在体外血浆中阻止单链尿激酶型纤溶酶原激活物(scu-PA)转化为双链尿激酶型纤溶酶原激活物(tcu-PA)的重要性。
Thromb Res. 1991 Sep 1;63(5):531-9. doi: 10.1016/0049-3848(91)90178-y.
10
Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator.低分子量单链尿激酶型纤溶酶原激活剂的成簇电荷至丙氨酸突变体的表达与特性分析
Thromb Haemost. 1994 Jan;71(1):134-40.

引用本文的文献

1
fibrinolytic activity of an enzyme purified from Bacillus amyloliquefaciens strain KJ10 isolated from .从……分离出的解淀粉芽孢杆菌菌株KJ10中纯化的一种酶的纤溶活性。 (注:原文中“isolated from”后面缺少具体内容)
Saudi J Biol Sci. 2021 Aug;28(8):4117-4123. doi: 10.1016/j.sjbs.2021.04.061. Epub 2021 May 1.
2
Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex.新型纳豆激酶-牛磺熊去氧胆酸复合物的制备及毒性评价
Asian J Pharm Sci. 2018 Mar;13(2):173-182. doi: 10.1016/j.ajps.2017.11.001. Epub 2017 Nov 10.
3
A low cost fermentation medium for potential fibrinolytic enzyme production by a newly isolated marine bacterium, sp. IND20.
一种用于新分离的海洋细菌IND20菌株生产潜在纤溶酶的低成本发酵培养基。
Biotechnol Rep (Amst). 2015 Jun 30;7:135-142. doi: 10.1016/j.btre.2015.06.005. eCollection 2015 Sep.
4
Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS.探索来自新菌株铜绿假单胞菌CMSS的纳豆激酶的体外溶栓活性。
Jundishapur J Microbiol. 2015 Oct 26;8(10):e23567. doi: 10.5812/jjm.23567. eCollection 2015 Oct.
5
Medium optimization for the production of fibrinolytic enzyme by Paenibacillus sp. IND8 using response surface methodology.利用响应面法对解淀粉芽孢杆菌IND8产纤溶酶的培养基进行优化。
ScientificWorldJournal. 2014 Jan 9;2014:276942. doi: 10.1155/2014/276942. eCollection 2014.